
Max Healthcare Institute Ltd. share price
NSE: MAXHEALTH · Healthcare
₹1,009.90 +6.63%
Closing price data, updated 17 Nov 2026. 52-week range: -14.8% from high, +26.7% above low.
Price₹1,009.90
Market cap₹98,295 Cr
P/E71.2
P/B8.67
ROE14.3%
ROCE12.6%
Debt / equity0.32
Dividend yield0.00%
EPS₹14.19
Book value₹116.43
Operating margin22.8%
Dipscan score44 / 100
Share: WhatsAppX / TwitterTelegram
Max Healthcare Institute Ltd. shareholding pattern
As of Sep 2026: Promoters 23.71%, FIIs 40.52%, DIIs 31.00%, Government 0.00%, Public 3.28%, Others 1.48%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 23.71% | 23.71% | 23.71% | 23.72% | 23.74% | 23.74% |
| FIIs | 40.52% | 41.78% | 45.39% | 50.55% | 51.80% | 54.76% |
| DIIs | 31.00% | 29.96% | 26.32% | 21.20% | 20.03% | 17.42% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 3.28% | 3.22% | 3.27% | 3.13% | 3.08% | 3.42% |
| Others | 1.48% | 1.33% | 1.31% | 1.38% | 1.35% | 0.66% |
| No. of Shareholders | 222,167 | 224,606 | 216,996 | 203,837 | 180,891 | 162,119 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +6.63% | +8.13% | +18.46% | -0.34% | -3.78% | -7.81% |
Growth
| Sales growth, 3 years | +22.4% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +9.3% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +20.3% |
| Latest quarter profit vs last year | -15.5% |
Strengths and weaknesses
Weaknesses
- Stock is trading at 8.67 times its book value
- Company has a low return on equity of 13.7% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 13.6% of profits over last 3 years
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
Frequently asked questions
What is the share price of Max Healthcare Institute Ltd.?
Max Healthcare Institute Ltd. (MAXHEALTH) last closed at ₹1,009.90 (+6.63% on the day).
What is the market cap of Max Healthcare Institute Ltd.?
About ₹98,295 Cr.
What is the P/E ratio of Max Healthcare Institute Ltd.?
The price-to-earnings ratio is 71.2, and return on equity is 14.3%.
Figures are calculated from company results and exchange prices and are for information only.